Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors

IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma

Longitudinal tumor ecosystem mapping defines glioblastoma treatment trajectories

Microglial Fructose Metabolism Is Essential for Glioblastoma Growth

Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma

STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways

Meningioma cell reprogramming and microenvironment interactions underlie brain invasion

Multiomics Image Analysis-Driven Insights into Tumor Microenvironment

Multiomics Image Analysis-Driven Insights into Tumor Microenvironment

Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures

Screening for Tumor Microtube-Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression